NASDAQ · Biotechnology

Mind Medicine (MindMed) Inc. (MNMD) Stock

$20.69 +0.44% NASDAQ: MNMD Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments.

Valuation

MetricValue
Price$20.69
Market Cap$1.56B
P/E Ratio-18.83
P/B Ratio18.36
P/S Ratio0.00
EPS (TTM)$-2.06
52-Week High$21.08
52-Week Low$4.70
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-102.48%
ROA-59.19%
ROCE-60.39%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.69

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-94.0M$-66.0M$-94.0M$-104.0M$-166.0M
Net Profit$-93.0M$-57.0M$-96.0M$-109.0M$-184.0M
EPS$-3.40$-1.84$-2.44$-0.15$-2.06
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$164.0M$170.0M$125.0M$302.0M$440.0M
Total Liabilities$12.0M$19.0M$46.0M$61.0M$108.0M
Cash$134.0M$142.0M$100.0M$274.0M$258.0M
Borrowings$0$0$14.0M$22.0M$0

Latest News

Ben & Jerry’s Foundation says operations at risk unless funding restored Just Food · Jul 16, 2026 Net Asset Value(s) Business Wire · Jul 16, 2026 Walmart's $114 folding electric scooter saves on gas and goes up to 19 miles per hour TheStreet · Jul 16, 2026 Andersen Consulting Adds Collaborating Firm Smartbridge Business Wire · Jul 16, 2026 Gartner Announces the Gartner Enterprise Risk, Audit & Compliance Conference 2026 in Grapevine Business Wire · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-46.0M$-50.0M$-64.0M$-79.0M$-132.0M
Investing Cash Flow$0$0$0$0$-152.0M
Financing Cash Flow$17.0M$17.0M$0$-8.0M$-13.0M
Net Cash Flow$53.0M$9.0M$-42.0M$174.0M$-16.0M
Free Cash Flow$-46.0M$-50.0M$-64.0M$-79.0M$-132.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.24
EV / EBITDA-21.91
FCF Yield-2.80%
Quick Ratio4.69
Interest Coverage-13.29
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATAI $7.25 +0.97% -8.44 $2.68B 0.00%
CLOV $4.76 +2.15% 48.35 $2.47B 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CYBN.NECybin Inc. — — — — 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%

About Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain. Furthermore, MM-110, an a3ß4 nicotinic cholinergic receptor antagonist, has successfully completed Phase 1 studies for managing opioid withdrawal. The company's portfolio also includes MM-402, an R-enantiomer of 3,4-methylenedioxymethamphetamine, aimed at treating the core symptoms associated with autism spectrum disorder. Its corporate headquarters are situated in Vancouver, Canada.

Mind Medicine (MindMed) Inc. is headquartered in CA.

Mind Medicine (MindMed) Inc. (MNMD) stock trades at $20.69 with a market capitalization of $1.56B. The stock is valued at a price-to-earnings (P/E) ratio of -18.83, price-to-book of 18.36, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.70 and $21.08, and currently trades 1.9% below its 52-week high.

On profitability, Mind Medicine (MindMed) Inc. generates a return on equity (ROE) of -102.48%, return on capital employed of -60.39%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.mindmed.co

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides